LabCompass

Suilan Zheng

Medicine · Purdue University West Lafayette

Established · publishing since 1994Rising activity

Publications

44

Citations

834

Est. group size

~5

Recurring co-author estimate

Active years

32

Publishing since 1994

Research summary
AI-generated

Suilan Zheng's research spans topics in medicine including red blood cell biology (such as how hemoglobin interacts with cell membrane proteins to regulate oxygen handling), single-cell transcriptomic profiling for identifying tissue and cell types, and areas connected to immunotherapy including CAR-T cell therapy. The work appears to combine cell biology and molecular biophysics with modern genomic profiling techniques. This body of work is based on a small number of publicly available publications, so the picture of the full research program is limited.

Red blood cell biology and oxygen transportSingle-cell transcriptomics and cell type identificationImmunotherapy and CAR-T cell therapyMolecular biophysics of blood proteinsComposite materials structural analysis (topic overlap, relevance unclear)

Publication output was sparse and irregular in the earlier part of the decade (0-2 papers per year, with gaps in 2020-2022) but increased notably starting in 2023, suggesting a recent uptick in research activity.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 2.8/year recently
2017: 1 publication172018: 1 publication182019: 2 publications192021222023: 7 publications7232024: 2 publications242025: 5 publications2526
Recent publications
Publishes in
  • Cancer Research×3
  • Blood×2
  • Frontiers in Immunology×2
  • bioRxiv (Cold Spring Harbor Laboratory)×2
  • Science Advances×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 20, 2026.

Claim or correct this profile